Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 12, 2026
Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: June 24, 2026
Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial.
Journal: Circulation. Cardiovascular interventions
Published: June 03, 2026
Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.
Journal: Neuro-oncology practice
Published: December 29, 2025
Balloon Pull Back Maneuver for Subacute Transcatheter Aortic Valve Migration.
Journal: JACC. Cardiovascular interventions
Published: November 23, 2025
Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years.
Journal: The New England journal of medicine
Published: October 27, 2025
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Journal: Lancet (London, England)
Published: September 30, 2025
The Clinical and Economic Consequences of Delayed Transcatheter Aortic Valve Replacement.
Journal: Structural heart : the journal of the Heart Team
Published: September 26, 2025
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial.
Journal: Lancet (London, England)
Published: September 15, 2025
Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Journal: European heart journal
Published: July 07, 2025
Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Journal: European heart journal
Published: July 07, 2025
Impact of Anticoagulation on Valve Hemodynamics Following Transcatheter Valve-In-Valve Implantation.
Impact of Anticoagulation on Valve Hemodynamics Following Transcatheter Valve-In-Valve Implantation.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: July 04, 2025
Last Updated: 09/26/2026